GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Rhino Biotech Ltd (OTCPK:RBRXF) » Definitions » PB Ratio

Rhino Biotech (Rhino Biotech) PB Ratio : (As of Jun. 15, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Rhino Biotech PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-15), Rhino Biotech's share price is $0.0001. Rhino Biotech's Book Value per Share for the quarter that ended in Dec. 2020 was $-0.00. Hence, Rhino Biotech's PB Ratio of today is .

The historical rank and industry rank for Rhino Biotech's PB Ratio or its related term are showing as below:

RBRXF's PB Ratio is not ranked *
in the Diversified Financial Services industry.
Industry Median: 1.83
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Rhino Biotech PB Ratio Historical Data

The historical data trend for Rhino Biotech's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhino Biotech PB Ratio Chart

Rhino Biotech Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Rhino Biotech Semi-Annual Data
Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Rhino Biotech's PB Ratio

For the Shell Companies subindustry, Rhino Biotech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhino Biotech's PB Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Rhino Biotech's PB Ratio distribution charts can be found below:

* The bar in red indicates where Rhino Biotech's PB Ratio falls into.



Rhino Biotech PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Rhino Biotech's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2020)
=0.0001/-0.002
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Rhino Biotech  (OTCPK:RBRXF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Rhino Biotech PB Ratio Related Terms

Thank you for viewing the detailed overview of Rhino Biotech's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhino Biotech (Rhino Biotech) Business Description

Traded in Other Exchanges
N/A
Address
294 Heywood House, British West Indies, Anguilla, AIA
Rhino Biotech Ltd formerly Eurasia Energy Ltd is a shell company.
Executives
Nicholas W Baxter 10 percent owner 220 SPRINGFIELD ROAD, ABERDEEN, ABERDEENSHIRE, SCOTLAND X0 AB15 6AU
Graham Crabtree officer: Chief Financial Officer 294 HEYWOOD HOUSE SOUTH HILL 1A AI-2640
Roger Thomas director 22 HENDERSON ROAD LONDON X0 SW18 3RR
Velda King director, officer: President, C.E.O. SUITE C102 10000 NORTH 31ST AVENUE PHOENIX AZ 85051
Gerald R Tuskey director, officer: C.F.O., Secretary/Treasurer 570 GRANVILLE STREET SUITE 400 VANCOUVER BC A1 V6C 3P1

Rhino Biotech (Rhino Biotech) Headlines

From GuruFocus

Rhino Biotech to Present at the Planet Microcap Showcase

By ACCESSWIRE ACCESSWIRE 05-04-2022